Skip to main content

Peer Review reports

From: Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis

Original Submission
8 Oct 2024 Submitted Original manuscript
18 Oct 2024 Author responded Author comments - Namrata Singh
Resubmission - Version 2
18 Oct 2024 Submitted Manuscript version 2
22 Oct 2024 Author responded Author comments - Namrata Singh
Resubmission - Version 3
22 Oct 2024 Submitted Manuscript version 3
25 Nov 2024 Reviewed Reviewer Report
26 Nov 2024 Reviewed Reviewer Report
11 Dec 2024 Author responded Author comments - Namrata Singh
Resubmission - Version 4
11 Dec 2024 Submitted Manuscript version 4
11 Dec 2024 Reviewed Reviewer Report
17 Dec 2024 Reviewed Reviewer Report
2 Jan 2025 Author responded Author comments - Namrata Singh
Resubmission - Version 5
2 Jan 2025 Submitted Manuscript version 5
3 Jan 2025 Author responded Author comments - Namrata Singh
Resubmission - Version 6
3 Jan 2025 Submitted Manuscript version 6
7 Jan 2025 Reviewed Reviewer Report
7 Jan 2025 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
8 Jan 2025 Editorially accepted
17 Jan 2025 Article published 10.1186/s41927-025-00457-3

You can find further information about peer review here.

Back to article page